• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm

By: Lowey Dannenberg, P.C. via GlobeNewswire
January 31, 2025 at 11:47 AM EST

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

On December 23, 2024, a complaint was filed against the Company and certain of its officers, alleging that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in China, which eventually resulted in the AstraZeneca China President being detained by Chinese law enforcement authorities; (3) as a result, AstraZeneca understated its legal risks; (4) the foregoing, once revealed, could materially harm AstraZeneca’s business activities in China; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

When investors learned the truth, AstraZeneca’s common stock declined precipitously, injuring investors.

If you suffered a loss of more than $200,000 in AstraZeneca’s securities, and wish to participate, or learn more, click here, or please contact our attorneys at (914) 733-7256 or via email to Andrea Farah (afarah@lowey.com) or Vincent R. Cappucci Jr. (vcappucci@lowey.com).

Any investor who wishes to serve as Lead Plaintiff must act before February 21, 2025.

About Lowey Dannenberg
Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has recovered billions of dollars on behalf of its clients.

Contact:
Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7234
Email: afarah@lowey.com

SOURCE: Lowey Dannenberg P.C.


Primary Logo

More News

View More
3 Reasons Tesla's Post-Earnings Hangover Looks Like a Buy
Today 14:39 EDT
Via MarketBeat
Tickers TSLA
Taiwan Semiconductor Could Boom on This AI Action Plan
Today 13:02 EDT
Via MarketBeat
Topics Artificial Intelligence Government
Tickers NVDA TSM
Meta's Q2 Earnings: Key Areas Investors Must Pay Attention To
Today 12:08 EDT
Via MarketBeat
Topics Artificial Intelligence World Trade
Tickers META
Top 5 AI & Autonomy Stocks Trading Under $15 With Big Potential
Today 11:27 EDT
Via MarketBeat
Topics Artificial Intelligence Retirement
Tickers AUR BBAI LIDR SOUN
American Airlines Earnings Miss, But Bulls Aren’t Backing Off
Today 10:39 EDT
Via MarketBeat
Topics Earnings Economy
Tickers AAL
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap